Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BX-001N by Bilix for Ischemia Reperfusion Injury: Likelihood of Approval
BX-001N is under clinical development by Bilix and currently in Phase I for Ischemia Reperfusion Injury. According to GlobalData, Phase...